Silent Stroke Clinical Trial
Official title:
the Effectiveness and Cost Effectiveness in Screening Gait Disorder of Silent Cerebrovascular Disease Assisted by Artificial Intelligent System and Clinical Doctors - A Randomized Parallel-controlled Study
This is a multi-center, randomized, double-blind, parallel-controlled, prospective study to
compare the effectiveness and cost-effectiveness of intelligent and doctor groups for gait
disorder screening.
Clinical data, including demographic characteristics, socioeconomic level, medical history,
assessment of neurological function, laboratory tests, imaging tests, health service
utilization, and costs will be collected from the subjects. All subjects will be divided into
an intelligent group and a doctor group according to a 1:1 ratio. The intelligent group will
undergo intelligent system evaluation, and the doctor group will undergo the clinician's
conventional treatment process. At the same time, all the subjects will undergo gold-standard
panel gait and cognitive rating scale assessments.
All subjects in the intelligent group will undergo tests to evaluate their nervous system
function, including the timed up-and-go test, mini-cognitive assessment, and sentence
repetition. Subjects will be recorded using a camera and microphone. The intelligent system
uses the built-in intelligent algorithm to analyze the gait video, sound, and picture to
provide information on gait features (stand-up time, turnaround time, stride length, step
velocity, stride length, step width, etc.), language features (pronunciation, intonation,
word order, language accuracy, language fluency, etc.), and clock features (contour, numbers,
pointers, etc.).
All subjects in the doctor group will consult with a doctor in the non-intelligent group
according to the routine treatment procedure. Doctors in the non-intelligent group are
required to be internal medicine clinicians with intermediate title or below, and they should
have registered their qualifications, relevant knowledge and training experience, educational
background, and other information in the early stage of the study. The doctors in the
non-intelligent group will make clinical diagnoses for the subjects based on routine medical
operations such as a history of the present illness, previous history, and physical
examination, and the data in medical records in the outpatient department will help determine
whether the subjects have gait disorders.
All subjects' walking videos will be assessed by the gold-standard panel, which will consist
of 2 experts of movement disorders. If there is any difference, a third expert will be
included in the evaluation. According to the clinical experience, the expert doctors will
evaluate the subjects' gait, and the results will be divided into normal gait and abnormal
gait.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04449523 -
Incidence of Silent Atrial Fibrillation in Patients With Clinically Silent Brain Ischemic Lesions
|
||
Completed |
NCT00831259 -
Risk of Stroke in Pulmonary Embolism With a Patent Foramen Ovale (PFO)
|
N/A | |
Recruiting |
NCT05369195 -
Cerebral Protection in Transcatheter Left Atrial Appendage Occlusion
|
N/A | |
Active, not recruiting |
NCT04808778 -
Stroke Prevention in Young Adults With Sickle Cell Anemia
|
||
Completed |
NCT04241289 -
Detection and Neurological Impact of Cerebrovascular Events in Cardiac Surgery Patients
|
||
Recruiting |
NCT05685069 -
Prevalence of Attributable Etiology and Modifiable Stroke Risk Factors in Patients With Covert Brain Infarctions
|
||
Not yet recruiting |
NCT04456348 -
Association Between Gait Assessed by Intelligent System and Cognitive Function in Silent Cerebrovascular Disease
|
||
Completed |
NCT04734587 -
Evaluation of Brain Damage Due to Coronary Angioplasty in Percutaneous Intervention Patients
|
||
Completed |
NCT03104556 -
Silent sTROke duriNG MitraClip Implantation
|